This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Sterious S , Smaldone MC , Plimack E , Uzzo RG , Canter D , Kutikov A
Prolonged natural progression from localized to symptomatic renal cell carcinoma
Can J Urol. 2012 Dec;19(6) :6578-80
AbstractSurgical excision is the gold standard therapy for clinically localized renal masses. Nevertheless, prognostication of the natural history of untreated renal cell carcinoma (RCC) remains a clinical challenge. While active surveillance (AS) has emerged as a viable treatment option in select patients with localized tumors and significant competing mortality risks, long term follow up data to assess the risk of disease progression are limited. We present a case of a localized, clinical stage T2 renal mass progressing to regional and systemic disease over 6 years, demonstrating that kinetics of disease progression may be prolonged and are yet to be fully understood.
NotesSterious, Steve Smaldone, Marc C Plimack, Elizabeth Uzzo, Robert G Canter, Daniel Kutikov, Alexander Canada The Canadian journal of urology Can J Urol. 2012 Dec;19(6):6578-80.